Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy
Scientific publications
Overview of the scientific articles published in specialist journals as part of the diabetes surveillance framework.
2024 |
| Diabetes mellitus, cardiovascular and chronic respiratory diseases in Germany and Europe – results of the European Health Interview Survey (EHIS 3, 2018 – 2020) Baumert J, Sarganas G, Kuhnert R, Thamm R, Steppuhn H, Waldhauer J, Hoebel J, Neuhauser H, Heidemann C (2024) J Health Monit. 2024;9(4):e 12920. doi: 10.25646/12920 |
| Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants NCD Risk Factor Collaboration (NCD-RisC), Heidemann C, Du Y, Scheidt-Nave C für das RKI (2024) Lancet; 404(10467):2077-2093. https://doi.org/10.1016/S0140-6736(24)02317-1 |
| Self-assessed quality of diabetes care Buchmann M, Du Y, Baumert J, Krause L, Weise S, Heidemann C (2024) Die Diabetologie, https://doi.org/10.1007/s11428-024-01255-0 |
| Diabetes self-management education programs: Results from a nationwide population-based study on characteristics of participants, rating of programs and reasons for non-participation Weise S, Du Y, Heidemann C, Baumert J, Frese T, Heise M (2024) PLoS One 12;19(9):e0310338. doi: 10.1371/journal.pone.0310338 |
| Diabetes surveillance - Laying the groundwork for non-communicable disease surveillance in Germany Scheidt-Nave C, Heidemann C, Reitzle L, Buchmann M, Ziese T, Icks A (2024) J Health Monit 9(2):e 12199. doi: 10.25646/12199 |
| Type 2 diabetes among people with selected citizenships in Germany: risk, healthcare, complications Buchmann M, Koschollek C, Du Y, Mauz E, Krause L, Neuperdt L, Tuncer O, Baumert J, Scheidt-Nave C, Heidemann C (2024) J Health Monit 9(2):e 12159. doi: 10.25646/12159 |
| Healthcare and health situation of adults with type 2 diabetes in Germany: The study GEDA 2021/2022-Diabetes Heidemann C, Du Y, Mauz E, Walther L, Peitz D, Müller A, Buchmann M, Allen J, Scheidt-Nave C, Baumert J (2024) J Health Monit 9(2):e 12128. doi: 10.25646/12128 |
| Diabetes-related amputations in Germany: analysis of time trend from 2015 to 2022 and differences by area-level socioeconomic deprivation Tuncer O, Du Y, Michalski N, Reitzle L (2024) J Health Monit. 9(2):e12026. doi: 10.25646/12026 |
| Prevalence of gestational diabetes mellitus in Germany: Temporal trend and differences by regional socioeconomic deprivation Reitzle L, Heidemann C, Krause L, Hoebel J, Scheidt-Nave C (2024) J Health Monit. 9(2):e12086. doi: 10.25646/12086 |
| Mortality of type 2 diabetes in Germany: additional insights from Gompertz models Kuss O, Baumert J, Schmidt C, Tönnies T (2024) Acta Diabetol. https://doi.org/10.1007/s00592-024-02237-w |
| Distribution and determinants of glycosylated hemoglobin in adolescents ‐ Results from a nationwide population-based survey in Germany Patelakis E, Schienkiewitz A, Truthmann J, Holl RW, Poethko-Müller C, Mensink GB, Heidemann C (2024) PLOS ONE. https://doi.org/10.1371/journal.pone.0296962 |
| Outpatient Health Service Utilization Among Adults with Diabetes, Hypertension and Cardiovascular Disease During the COVID-19 Pandemic - Results of Population-Based Surveys in Germany from 2019 to 2021 Du Y, Baumert J, Damerow S, Rommel A, Neuhauser H, Heidemann C (2024) J Multidiscip Healthc. 17:675-687. https://doi.org/10.2147/JMDH.S445899 |
| Intersectional analysis of social disparities in type 2 diabetes risk among adults in Germany: results from a nationwide population-based survey Färber F, Alonso-Perez E, Heidemann C, Du Y, Stadler G, Gellert P, O'Sullivan JL (2024) BMC Public Health 24(1):498. https://doi.org/10.1186/s12889-024-17903-5 |
| Referenzauswertungen für die Schätzung von Prävalenz, Inzidenz und Mortalität Public-Health-relevanter Erkrankungen auf Basis von Routinedaten Krause L, Reitzle L, Hess S, Ziese T, Adewuyi D (2024) Bundesgesundheitsbl 67:139–148. https://doi.org/10.1007/s00103-023-03821-1 |
| The Agreement Between Diagnoses as Stated by Patients and Those Contained in Routine Health Insurance Data: Results of a data linkage study Vogelgesang F, Thamm R, Frerk T, Grobe TG, Saam J, Schumacher C, Thom J (2024) Dtsch Arztebl Int 121:141-7. DOI: 10.3238/arztebl.m2023.0250 |
| Altered mortality from selected non-communicable diseases during the COVID-19 pandemic in Germany in 2020 and 2021 Baumert J, Scheidt-Nave C, Steppuhn H, Tetzlaff F, Kraywinkel K, an der Heiden M, Wengler A, Maier B (2024) Dtsch Arztebl International 121(4):135-136. DOI: 10.3238/arztebl.m2023.0262 |
| Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c NCD Risk Factor Collaboration (NCD-RisC); Du Y, Heidemann C, Scheidt-Nave C for the Robert Koch Institute (2023) Nat Med. 29(11):2885-2901. doi: 10.1038/s41591-023-02610-2 |
| Surveillance of the mental health of Germany's adults using monthly population-based survey data Walther L, Junker S, Thom J, Peitz D, Mauz E (2023) Eur J Public Health 33 (Supplement_2). https://doi.org/10.1093/eurpub/ckad160.491 |
| High-frequency surveillance of mental health indicators in the adult population of Germany: trends from 2022 to 2023 Walther L, Junker S, Thom J, Hölling H, Mauz E (2023) Dtsch Arztebl Int (120): 736-7. DOI: 10.3238/arztebl.m2023.0180 |
| Überblick über Strategien, Indikatorensysteme und Ergebnisdissemination zu nichtübertragbaren Erkrankungen Buchmann M, Patelakis E, Kettlitz R, Mumm R, Reitzle L, Heidemann C (2023) Epidemiologisches Bulletin (26):3-13. DOI 10.25646/11536 |
| Incidence of type 1 and type 2 diabetes before and during the COVID-19 pandemic in Germany: analysis of routine data from 2015 to 2021 Reitzle L, Heidemann C, Jacob J, Pawlowska-Phelan D, Ludwig M, Scheidt-Nave C (2023) J Health Monit 8(S5): 2–25. DOI 10.25646/11730 |
| SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration (2023). European Heart Journal 44(28):2544-2556. doi: 10.1093/eurheartj/ehad260 |
| Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up. Heidemann C, Sarganas G, Du Y, Gaertner B, Poethko-Müller C, Cohrdes C, Schmidt S, Schlaud M, Scheidt-Nave C (2023) BMC Public Health 23:1587. doi: 10.1186/s12889-023-16524-8 |
| Gesundheit von Menschen mit ausgewählten Staatsangehörigkeiten in Deutschland: Prävalenzen nichtübertragbarer Erkrankungen und damit assoziierte soziale sowie migrationsbezogene Faktoren. Bartig S, Bug M, Koschollek C, Kajikhina K, Blume M, Siegert M, Heidemann C, Walther L, Neuhauser H, Hövener C (2023) Bundesgesundheitsbl 66:1071-1082. doi: 10.1007/s00103-023-03767-4 |
| Update of the National Diabetes Surveillance: Overview on indicators from the fields of action improving the early detection and treatment of diabetes, reducing the complications of diabetes and reducing the burden and costs of disease Tuncer O, Du Y, Baumert J, Reitzle L, Heidemann C (2023) Die Diabetologie. doi: 10.1007/s11428-023-01069-6 |
| Incidence, prevalence and care of type 1 diabetes in children and adolescents in Germany: Time trends and regional socioeconomic situation Buchmann M, Tuncer O, Auzanneau M, Eckert AJ, Rosenbauer J, Reitzle L, Heidemann C, Holl RW, Thamm R (2023) J Health Monit 8(2): 57–78.doi: 10.25646/1143 |
| Development and Internal Validation of Case Definitions for Prevalence Estimation of Microvascular Complications of Diabetes in Routine Data Reitzle L, Köster I, Tuncer O, Schmidt C, Meyer I (2023) Gesundheitswesen (eFirst). doi: 10.1055/a-2061-6954 |
| Diabetes-related distress and associated factors among adults with diabetes in Germany: Results of the nationwide study “Disease knowledge and information needs – Diabetes mellitus 2017” Du Y, Baumert J, Paprott R, Färber F, Nübel J, Hermanns N, Heidemann C, Scheidt-Nave C (2023) Journal of psychosomatic research 164:111073. doi: 10.1016/j.jpsychores.2022.111073 |
| Pregnancy Complications in Women With Pregestational and Gestational Diabetes Mellitus Reitzle L, Heidemann C, Baumert J, Kaltheuner M, Adamczewski H, Icks A, Scheidt-Nave C (2023) Dtsch Arztebl Int 120: 81–6. doi: 10.3238/arztebl.m2022.0387 |
| Perceived Chronic Stress Is Associated with the German Diabetes Risk Score (GDRS) Among Adults Without Known Diabetes in Germany Nübel J, Du Y, Baumert J, Hapke U, Färber F, Heidemann C, Scheidt-Nave C (2023) Psychosomatic medicine 10.1097/PSY.0000000000001183. doi: 10.1097/PSY.0000000000001183 |
| Algorithm for the Classification of Type 1 and Type 2 Diabetes Mellitus for the Analysis of Routine Data. Reitzle L, Ihle P, Heidemann C, Paprott R, Köster I, Schmidt C (2023) Gesundheitswesen 85(S 02): S119-S126. doi: 10.1055/a-1791-0918 |
| Evidenzsynthesen in Public Health: ein Überblick Barnes B, Buchmann M, Mumm R, Nowossadeck E, Peitz D, Prütz F, Wachtler B, Wienecke A (2022) Z Evid Fortbild Qual Gesundhwes 175:17-28. doi: https://doi.org/10.1016/j.zefq.2022.09.003 |
| Non-utilisation of health care services during the COVID-19 pandemic: Results of the CoMoLo study. Heidemann C, Reitzle L, Schmidt C, Fuchs J, Prütz F, Scheidt-Nave C (2022) Journal of Health Monitoring 7(S1): 2 –19. doi: 10.25646/9564 |
| Sex-specific impact of major depressive disorder on 12-year change in glycaemic status: Results from a nationwide cohort study of adults without diabetes in Germany. Nübel J, Truthmann J, Heidemann C, Du Y, Paprott R, Hapke U, Kruse J, Scheidt-Nave C, Baumert J (2022) Diabetic Medicine 39:e14767. doi:10.1111/dme.14767 |
| German diabetes risk score for the determination of the individual type 2 diabetes risk—10-year prediction and external validations Schiborn C, Paprott R, Heidemann C, Kühn T, Fritsche A, Kaaks R, Schulze M B (2022) Deutsches Arzteblatt international (Forthcoming), arztebl.m2022.0268. Advance online publication. https://doi.org/10.3238/arztebl.m2022.0268 |
| Participation in structured diabetes self-management education programs and its associations with self-management behaviour - a nationwide population-based study. Carmienke S, Fink A, Baumert J, Heidemann C, Du Y, Frese T, Heise M (2022) Patient education and counseling 105(4), 843–850. https://doi.org/10.1016/j.pec.2021.07.017 |
| Structured diabetes self-management education and its association with perceived diabetes knowledge, information, and disease distress: Results of a nationwide population-based study. Heise M, Heidemann C, Baumert J, Du Y, Frese T, Avetisyan M, Weise S (2022) Primary care diabetes 16(3), 387–394. https://doi.org/10.1016/j.pcd.2022.03.016 |
| Diabetes surveillance at the Robert Koch Institute – pilot project for the development of an NCD surveillance in Germany. Heidemann C, Reitzle L, Ziese T, Scheidt-Nave C (2021) Public Health Forum 29(4):277-281. doi: 10.1515/pubhef-2021-0081 |
| Health situation of adults in Germany – Results for selected indicators from GEDA 2019/2020-EHIS. Heidemann C, Scheidt-Nave C, Beyer A-K, Baumert J, Thamm R, Maier B, Neuhauser H, Fuchs J, Kuhnert R, Hapke U (2021) Journal of Health Monitoring 6(3): 3-25. doi: 10.25646/8459. |
| Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040. Tönnies T, Baumert J, Heidemann C, von der Lippe E, Brinks R, Hoyer A (2021) Population Health Metrics 19(1). doi: 10.1186/s12963-021-00266-z. |
| Making Use of Comparable Health Data to Improve Quality of Care and Outcomes in Diabetes: The EUBIROD Review of Diabetes Registries and Data Sources in Europe. Carinci F, Štotl I, Cunningham SG, Poljicanin T, Pristas I, Traynor V, Olympios G, Scoutellas V, Azzopardi J, Doggen K, Sandor J, Adany R, Løvaas KF, Jarosz-Chobot P, Polanska J, Pruna S, de Lusignan S, Monesi M, Di Bartolo P, Scheidt-Nave C, Heidemann C, Zucker I, Maurina A, Lepiksone J, Rossing P, Arffman M, Keskimäki I, Gudbjornsdottir S, Di Iorio CT, Dupont E, de Sabata S, Klazinga N, Benedetti MM (2021) Frontiers in Clinical Diabetes and Healthcare 2. doi: 10.3389/fcdhc.2021.744516. |
| Perceived Access to Health Care Services and Relevance of Telemedicine during the COVID-19 Pandemic in Germany. Reitzle L, Schmidt C, Färber F, Huebl L, Wieler LH, Ziese T, Heidemann C (2021) International Journal of Environmental Research and Public Health 18(14): 7661. doi: 10.3390/ijerph18147661. |
| Diabetes mellitus and comorbidities – A cross-sectional study with control group based on nationwide ambulatory claims data. Schmidt C, Reitzle L, Paprott R, Bätzing J, Holstiege J (2021) Journal of Health Monitoring 6(2): 19-35. doi: 10.25646/8327. |
| Gestational diabetes in Germany: Development of screening participation and prevalence. Reitzle L, Schmidt C, Heidemann C, Icks A, Kaltheuner M, Ziese T, Scheidt-Nave C (2021) Journal of Health Monitoring 6(2): 3-18. doi: 10.25646/8325. |
| Utilisation of outpatient medical services by people with diagnosed diabetes during the COVID-19 pandemic in Germany. Du Y, Baumert J, Damerow S, Rommel A, Scheidt-Nave C, Heidemann C (2021) Journal of Health Monitoring 6(2): 51-58. doi: 10.25646/8333. |
| Self-assessed quality of care among adults with diagnosed diabetes in Germany. Baumert J, Paprott R, Du Y, Heidemann C, Scheidt-Nave C (2021) Journal of Health Monitoring 6(2): 36-42. doi: 10.25646/8329. |
| Healthy life years among people with and without diabetes in Germany. Baumert J, Heidemann C, Reitzle L, Schmidt C (2021) Journal of Health Monitoring 6(2): 43-50. doi: 10.25646/8331. |
| Patterns and associated factors of diabetes self-management: Results of a latent class analysis in a German population-based study. Heise M, Fink A, Baumert J, Heidemann C, Du Y, Frese T, Carmienke S (2021) PLoS One 16(3): e0248992. doi: 10.1371/journal.pone.0248992. |
| Are depressive symptoms associated with quality of care in diabetes? Findings from a nationwide population-based study. Jung A, Du Y, Nübel J, Busch MA, Heidemann C, Scheidt-Nave C, Baumert J (2021) BMJ Open Diabetes Res Care 9(1). doi: 10.1136/bmjdrc-2020-001804. |
| Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013–2014. Schmidt C, Reitzle L, Heidemann C, Paprott R, Ziese T, Scheidt-Nave C, Baumert J (2021) BMJ Open 11(1): e041508. doi: 10.1136/bmjopen-2020-041508. |
| Estimating the impact of tax policy interventions on the projected number and prevalence of adults with type 2 diabetes in Germany between 2020 and 2040. Tönnies T, Heidemann C, Paprott R, Seidel-Jacobs E, Scheidt-Nave C, Brinks R, Hoyer A (2021) BMJ Open Diabetes Res Care 9(1). doi: 10.1136/bmjdrc-2020-001813. |
| Selbst eingeschätzte medizinische Versorgung im Verlauf der SARS-CoV-2-Pandemie in Deutschland: Ergebnisse der COSMO-Studie. Heidemann C, Paprott R, Huebl L, Scheidt-Nave C, Reitzle L (2020) Epidemiologisches Bulletin 46: 3-10. doi: 10.25646/7208. |
| Care for the chronically ill in Germany – The challenges during the COVID-19 pandemic. Scheidt-Nave C, Barnes B, Beyer A-K, Busch M, Hapke U, Heidemann C, Imhoff M, Mumm R, Paprott R, Steppuhn H, von Berenberg-Gossler P, Kraywinkel K (2020) Journal of Health Monitoring 5(S10): 2-27. doi: 10.25646/7168. |
| Factors associated with undiagnosed type 2 diabetes in Germany: results from German Health Interview and Examination Survey for Adults 2008-2011. Du Y, Baumert J, Paprott R, Teti A, Heidemann C, Scheidt-Nave C (2020) BMJ Open Diabetes Res Care 8(1). doi: 10.1136/bmjdrc-2020-001707. |
| Einschätzungen zur Prävalenz mikrovaskulärer Folgeerkrankungen bei Diabetes mellitus in Deutschland. Analyse von Versichertendaten aller gesetzlichen Krankenkassen für die Jahre 2012 und 2013. Reitzle L, Schmidt C, Du Y, Icks A, Hagen B, Ziese T, Scheidt-Nave C (2020) Bundesgesundheitsbl 63:1219-1230. doi: 10.1007/s00103-020-03211-x. |
| Gesundheitsberichterstattung im Rahmen von Public Health Surveillance: Das Beispiel Diabetes. Reitzle L, Paprott R, Färber F, Heidemann C, Schmidt C, Thamm R, Scheidt-Nave C, Ziese T (2020) Bundesgesundheitsbl 63(9): 1099-1107. doi: 10.1007/s00103-020-03201-z. |
| Participation in structured diabetes mellitus self-management education program and association with lifestyle behavior: results from a population-based study. Carmienke S, Baumert J, Gabrys L, Heise M, Frese T, Heidemann C, Fink A (2020) BMJ Open Diabetes Res Care 8(1). doi: 10.1136/bmjdrc-2019-001066. |
| Sports activity patterns and cardio-metabolic health over time among adults in Germany: Results of a nationwide 12-year follow-up study. Gabrys L, Baumert J, Heidemann C, Busch M, Finger JD (2020) J Sport Health Sci. Online ahead of print. doi: 10.1016/j.jshs.2020.07.007. |
| Was weiß die Allgemeinbevölkerung über Diabetes? Paprott R, Heidemann C (2020) diabetologie-online; Diabetes-Forum 1(2): 22-26. |
| Health App Use and Its Correlates Among Individuals With and Without Type 2 Diabetes: Nationwide Population-Based Survey. Stühmann LM, Paprott R, Heidemann C, Baumert J, Hansen S, Zahn D, Scheidt-Nave C, Gellert P (2020) JMIR Diabetes 5(2): e14396. doi: 10.2196/14396. |
| Psychometric properties of a nationwide survey for adults with and without diabetes: the "disease knowledge and information needs - diabetes mellitus (2017)" survey. Stühmann LM, Paprott R, Heidemann C, Ziese T, Hansen S, Zahn D, Scheidt-Nave C, Gellert P (2020) BMC Public Health 20(1): 192. doi: 10.1186/s12889-020-8296-6. |
| Prävalenz und Inzidenz des dokumentierten Diabetes mellitus – Referenzauswertung für die Diabetes-Surveillance auf Basis von Daten aller gesetzlich Krankenversicherten. Schmidt C, Reitzle L, Dreß J, Rommel A, Ziese T, Heidemann C (2020) Bundesgesundheitsbl 63(1): 93-102. doi: 10.1007/s00103-019-03068-9. |
| Aufbau einer Diabetes-Surveillance in Deutschland – Ergebnisse der ersten Projektphase (2015-2019). Heidemann C, Paprott R, Schmidt C, Reitzle L, Baumert J, Du Y, Patelakis E, Arslan S, Ziese T, Scheidt-Nave C (2019) Epidemiologisches Bulletin 45: 473-478. doi: 10.25646/6403. |
| Perceived diabetes risk and related determinants in individuals with high actual diabetes risk: results from a nationwide population-based survey. Heidemann C, Paprott R, Stühmann LM, Baumert J, Mühlenbruch K, Hansen S, Schiborn C, Zahn D, Gellert P, Scheidt-Nave C (2019) BMJ Open Diabetes Res Care 7(1): e000680. doi: 10.1136/bmjdrc-2019-000680. |
| Fieberkrämpfe, Epilepsie, Migrane, Diabetes und Herzerkrankungen sowie Masern, Windpocken und Keuchhusten bei Kindern und Jugendlichen in Deutschland : Ergebnisse aus KiGGS Welle 2. Poethko-Müller C, Thamm R, Heidemann C, Busch M, Neuhauser H (2019) Bundesgesundheitsbl 62(10): 1162-1173. doi: 10.1007/s00103-019-03004-x. |
| Editorial: Diabetes surveillance in Germany – status and perspectives. Scheidt-Nave C, Icks A (2019) Journal of Health Monitoring 4(2): 3-10. doi: 10.25646/5985. |
| Social inequality and diabetes mellitus – developments over time among the adult population in Germany. Heidemann C, Du Y, Baumert J, Paprott R, Lampert T, Scheidt-Nave C (2019) Journal of Health Monitoring 4(2): 11-28. doi: 10.25646/5986. |
| Secondary data in diabetes surveillance – co-operation projects and definition of references on the documented prevalence of diabetes. Schmidt C, Heidemann C, Rommel A, Brinks R, Claessen H, Dreß J, Hagen B, Hoyer A, Laux G, Pollmanns J, Präger M, Böhm J, Drösler S, Icks A, Kümmel S, Kurz C, Kvitkina T, Laxy M, Maier W, Narres M, Szecsenyi J, Tönnies T, Weyermann M, Paprott R, Reitzle L, Baumert J, Patelakis E, Ziese T (2019) Journal of Health Monitoring 4(2): 50-63. doi: 10.25646/5988. |
| An international comparison of noncommunicable disease reporting: the case of diabetes mellitus. Reitzle L, Schmidt C, Scheidt-Nave C, Ziese T (2019) Journal of Health Monitoring 4(2): 64-85. doi: 10.25646/5989.. |
| Projected number of people with diagnosed Type 2 diabetes in Germany in 2040. Tönnies T, Röckl S, Hoyer A, Heidemann C, Baumert J, Du Y, Scheidt-Nave C, Brinks R (2019) Diabet Med 36: 1217–1225. doi: 10.1111/dme.13902. |
| Diabetes Mellitus in der medizinischen Rehabilitation - Inanspruchnahme rehabilitativer Massnahmen im Zeitraum 2006-2013. Schmidt C, Baumert J, Gabrys L, Ziese T (2019) Rehabilitation (Stuttg) 58(4): 253-259. doi: 10.1055/a-0645-9060. |
| Gender differences in cardiovascular risk profiles and diabetes care among adults with type 2 diabetes in Germany. Du Y, Baumert J, Paprott R, Neuhauser H, Heidemann C, Scheidt-Nave C (2019) Diabetes Metab 45(2): 204-206. doi: 10.1016/j.diabet.2018.05.011. |
| Diabetes im Blick – Nationale Diabetes-Surveillance. Schmidt C, Du Y, Baumert J, Reitzle L, Heidemann C, Paprott R, Ziese T, Scheidt-Nave C (2019) Der Diabetologe 15 (2):120-127. doi: 10.1007/s11428-018-0419-7. |
| Time trends in healthy lifestyle among adults in Germany: Results from three national health interview and examination surveys between 1990 and 2011. Finger JD, Busch MA, Heidemann C, Lange C, Mensink GBM, Schienkiewitz A (2019) PLoS One 14(9): e0222218. doi: 10.1371/journal.pone.0222218. |
| Individual and area-level determinants associated with C-reactive protein as a marker of cardiometabolic risk among adults: Results from the German National Health Interview and Examination Survey 2008-2011. Steppuhn H, Laußmann D, Baumert J, Kroll L, Lampert T, Plaß D, Scheidt-Nave C, Heidemann C (2019) PLoS One 14(2): e0211774. doi: 10.1371/journal.pone.0211774. |
| Glycaemic status and depressive symptoms among adults in Germany: results from the German Health Interview and Examination Survey for Adults (DEGS1). Weikert B, Buttery AK, Heidemann C, Rieckmann N, Paprott R, Maske UE, Scheidt-Nave C, Busch MA (2018) Diabet Med 35(11): 1552-1561. doi: 10.1111/dme.13707. |
| National public health system responses to diabetes and other important noncommunicable diseases: Background, goals, and results of an international workshop at the Robert Koch Institute. Reitzle L, Hansen S, Paprott R, Achtermann W, Baumert J, Bogaert P, Curt L, Diem P, Du Y, Eiser S, Fitzpatrick J, Heidemann C, Jousilahti P, Kulzer B, Lindström J, Neuhauser H, van Oyen H, Pelletier L, Schmidt C, Valabhji J, Weitgasser R, Ziese T, Zahn D, Scheidt-Nave C (2018) Bundesgesundheitsbl 61 (10): 1300–1306. doi: 10.1007/s00103-018-2806-z. |
| Selecting and defining indicators for diabetes surveillance in Germany. Gabrys L, Heidemann C, Baumert J, Teti A, Du Y, Paprott R, Ziese T, Banzer W, Böhme M, Borrmann B, Busse R, Freitag M, Hagen B, Holl R, Icks A, Kaltheuner M, Koch K, Kümmel S, Kuhn J, Kuß O, Laux G, Schubert I, Szecsenyi J, Uebel T, Zahn D, Scheidt-Nave C (2018) Journal of Health Monitoring 3(S3): 3-21. doi: 10.17886/RKI-GBE-2018-063. |
| First results from the study ‘Disease knowledge and information needs - Diabetes mellitus (2017)’. Paprott R, Heidemann C, Stühmann LM, Baumert J, Du Y, Hansen S, Zeisler M-L, Lemcke J, Beyhl S, Kuhnert R, Schmidt C, Gabrys L, Teti A, Ziese T, Schmich P, Gellert P, Zahn D, Scheidt-Nave C (2018) Journal of Health Monitoring 3(S3): 22-60. doi: 10.17886/RKI-GBE-2018-064. |
| Besteht bei Rehabilitanden mit Typ-2-Diabetes ein Zusammenhang zwischen DMP-Einschreibung und Bezug einer Erwerbsminderungsrente? Schmidt C, Hagen B, Baumert J, Ziese T (2018) Gesundheitswesen (efirst). doi: 10.1055/a-0586-8851. |
| Association between random glucose and all-cause mortality: findings from the mortality follow-up of the German National Health Interview and Examination Survey 1998. Baumert J, Heidemann C, Paprott R, Du Y, Scheidt-Nave C (2018) BMC Endocr Disord 18(1): 95. doi: 10.1186/s12902-018-0319-2. |
| Regionalisierung der Gesundheitsberichterstattung am Beispiel Diabetes-Surveillance. Ziele und Ergebnisse des Bund-Länder-Gesprächs am Robert Koch-Institut. Gabrys L, Heidemann C, Teti A, Borrmann B, Gawrich S, Maulbecker-Armstrong C, Fertmann R, Schubert U, Schmidt C, Baumert J, Paprott R, Du Y, Scheidt-Nave C, Ziese T. (2017) Bundesgesundheitsbl 60(10): 1147-1152 doi: 10.1007/s00103-017-2616-8. |
| All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany. Röckl S, Brinks R, Baumert J, Paprott R, Du Y, Heidemann C, Scheidt-Nave C (2017) BMJ Open Diab Res Care 2017(5): e000451. doi:10.1136/bmjdrc-2017-000451. |
| Prevalence, incidence and mortality of diabetes mellitus in adults in Germany – A review in the framework of the Diabetes Surveillance. Heidemann C, Scheidt-Nave C (2017) Journal of Health Monitoring 2(3): 98-121. doi: 10.17886/RKI-GBE-2017-062. |
| Diabetes-Surveillance: Beispiel für den Aufbau einer Public-Health-Surveillance zu nichtübertragbaren Krankheiten in Deutschland. Gabrys L, Schmidt C, Baumert J, Heidemann C, Du Y, Paprott R, Teti A, Ziese T, Scheidt-Nave C (2017) Epidemiologisches Bulletin 45:513 – 515. doi: 10.17886/EpiBull-2017-064. |
| Integration von Sekundärdaten in die Nationale Diabetes-Surveillance: Hintergrund, Ziele und Ergebnisse des Sekundärdaten-Workshops am Robert Koch-Institut. Schmidt, C, Bätzing-Feigenbaum, J, Bestmann, A, Brinks R, Goffrier B, Hagen B, Laux G, Pollmanns J, Schröder H, Stahl T, Baumert J, Du Y, Gabrys L, Heidemann C, Paprott R, Scheidt-Nave C, Teti A, Ziese T (2017) Bundesgesundheitsbl 60(6): 656-661 doi: 10.1007/s00103-017-2552-7. |
| Diabetes Surveillance in Germany – Background, concept and prospects. Gabrys L, Schmidt C, Heidemann C, Baumert J, Du Y, Paprott R, Teti A, Wolf I-K, Ziese T, Scheidt-Nave C (2017) Journal of Health Monitoring 2(1): 83-95. doi: 10.17886/RKI-GBE-2017-022. |
| Proceedings of the International Workshop ‘Development of a National Diabetes Surveillance System in Germany – Core Indicators and Conceptual Framework’: Berlin, Germany. 11–12 July 2016. Teti A, Gabrys L, Ziese T, Scheidt-Nave C, Heidemann C, Schmidt C, Wolf I-K, Du Y, Paprott R, Baumert J, Gregg EW, Geiss L, Mainz J, Jørgensen M, Johnson J, Carinci F, Wild S (2017) BMC Proc 11(Suppl 3): 3. doi: 10.1186/s12919-016-0070-5. |
| Temporal changes in predicted risk of type 2 diabetes in Germany: findings from the German Health Interview and Examination Surveys 1997-1999 and 2008-2011. Paprott R, Mensink GBM, Schulze MB, Thiele S, Mühlenbruch K, Scheidt-Nave C, Heidemann C (2017) BMJ Open 7(7): e013058. doi: 10.1136/bmjopen-2016-013058. |
| Regionale Unterschiede in der Prävalenz von kardiovaskulären Risikofaktoren bei Männern und Frauen in Deutschland. Diederichs C, Neuhauser H, Kroll L, Lange C, Mensink G, Dornquast C, Heidemann C, Scheidt-Nave C, Busch M (2017) Bundesgesundheitsbl 60(2): 151-162. doi: 10.1007/s00103-016-2493-6. |
| Time Trends in Cardiometabolic Risk Factors in Adults. Finger JD, Busch MA, Du Y, Heidemann C, Knopf H, Kuhnert R, Lampert T, Mensink GBM, Neuhauser HK, Schaffrath Rosario A, Scheidt-Nave C, Schienkiewitz A, Truthmann J, Kurth B-M (2016) Dtsch Arztebl International 113(42). doi: 10.3238/arztebl.2016.0712. |
| The Prevalence of Renal Failure. Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A (2016) Dtsch Arztebl International 113(6): 85-91. doi: 10.3238/arztebl.2016.0085. |
| Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997-1999 and 2008-2011. Heidemann C, Du Y, Paprott R, Haftenberger M, Rathmann W, Scheidt-Nave C (2016) Diabet Med 33(10): 1406-1414. doi: 10.1111/dme.13008. |
| Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. NCD Risk Factor Collaboration (NCD-RisC), für das RKI: Du Y, Heidemann C, Scheidt-Nave C (2016) Lancet 387(10027): 1513-1530. doi: 10.1016/S0140-6736(16)00618-8.) |
| Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys. Paprott R, Mühlenbruch K, Mensink GB, Thiele S, Schulze MB, Scheidt-Nave C, Heidemann C (2016) BMJ Open Diabetes Res Care 4(1): e000280. doi: 10.1136/bmjdrc-2016-000280. |
| Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997-1999 and 2008-2011. Du Y, Heidemann C, Schaffrath Rosario A, Buttery A, Paprott R, Neuhauser H, Riedel T, Icks A, Scheidt-Nave C (2015) BMJ Open Diabetes Res Care 3: e000135. doi: 10.1136/bmjdrc-2015-000135. |
| Association between hemoglobin A1c and all-cause mortality: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998. Paprott R, Schaffrath Rosario A, Busch MA, Du Y, Thiele S, Scheidt-Nave C, Heidemann C (2015) Diabetes Care 38(2): 249-256. doi: 10.2337/dc14-1787. |